A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)

Trial Profile

A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Feb 2016

At a glance

  • Drugs Mexiletine (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Feb 2016 Results published in the Neurology
    • 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 25 Apr 2015 Status changed from active, no longer recruiting to completed according to results presented at the 67th Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top